Skip to main content

AusPAR: Osimertinib mesilate

Australian Public Assessment Report
Device/Product Name
Tagrisso
Active ingredients
Osimertinib mesilate
AusPAR Date
Published
Submission Number
PM-2017-04579-1-4
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site